Obstetrics, gynecology and reproductive medicine guidelines

Menopause

PubMed Free Full Text

Menopause, hormone replacement therapy

 

Asia

• Climacteric
  • Updated clinical recommendations for the use of tibolone in Asian women [2010]

Australia

• Australian Journal of General Practice
  • Making choices at menopause [2019]

• BMC Women's Health
  • Menopause and the influence of culture: another gap for Indigenous Australian women? [2012]

Australia, New Zealand

• Australasian Menopause Society
  • Menopause Management

Canada

• Canadian Agency for Drugs and Technologies in Health
  • Oral Progesterone for the Treatment of Menopausal Symptoms: A Review of the Clinical Evidence [2014]

• Society of Obstetricians and Gynaecologists of Canada
  • Managing Menopause Chapter 7 Ongoing Management of Menopausal Women and Those With Special Considerations [2014]
  • Managing Menopause Chapter 6 Prescription Therapeutic Agents [2014]
  • Managing Menopause Chapter 1 Assessment and Risk Management of Menopausal Women [2014]
  • Managing Menopause Abstract and Summary Statement [2014]

Europe

• European Menopause and Andropause Society
  • Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement [2021]
  • A model of care for healthy menopause and ageing: EMAS position statement [2016]
  • EMAS position statement: The ten point guide to the integral management of menopausal health [2015]
  • EMAS Position Statements
  • EMAS Clinical Guides

• European Society of Human Reproduction and Embryology
  • Perimenopausal risk factors and future health [2011]

Germany

• Archives of Gynecology and Obstetrics
  • Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version [2011]

• Deutsches Ärzteblatt International
  • The Treatment of Climacteric Symptoms [2012]

Germany, Austria

• Geburtshilfe und Frauenheilkunde
  • Perimenopause and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020) [2021]

India

• Journal of Mid-Life Health
  • Clinical Practice Guidelines on Menopause: An Executive Summary and Recommendations: Indian Menopause Society 2019–2020 [2020]

International

• Climacteric
  • Global Consensus Statement on Menopausal Hormone Therapy [2013]

• European Menopause and Andropause Society
  • European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis [2020]

• Fertility and Sterility
  • Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging [2012]

• PLoS Medicine
  • Relationships between intensity, duration, cumulative dose, and timing of smoking with age at menopause: A pooled analysis of individual data from 17 observational studies [2018]

Ireland

• Ireland's Health Services
  • Ovarian Cysts in Postmenopausal Women [2017]

Italy

• BMC Women's Health
  • Informing women about hormone replacement therapy: the Consensus conference statement [2009]

Poland

• Przeglad Menopauzalny = Menopause Review
  • Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society – state of knowledge as of December 2013 [2014]

Republic of Korea

• Journal of Korean Medical Science
  • Trends of Premature and Early Menopause: a Comparative Study of the US National Health and Nutrition Examination Survey and the Korea National Health and Nutrition Examination Survey [2020]

• Journal of Menopausal Medicine
  • The 2020 Menopausal Hormone Therapy Guidelines [2020]

United Kingdom

• British Menopause Society
  • British Menopause Society further update on HRT supply shortages (20 July 2021) [2021]
  • Joint BMS / FSRH / RCGP / RCOG framework for restoration of menopause services in response to COVID-19 [2020]
  • Bioidentical HRT [2019]

• National Institute for Health and Care Excellence
  • Menopause: diagnosis and management [2019]
  • Menopause (Quality standard) [2017]
  • Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate [2016]
  • Menopause

• Royal College of Nursing
  • The Menopause and Work: Guidance for RCN Representatives [2020]
  • Menopause: RCN Guidance for Nurses, Midwives and Health Visitors [2020]

• Royal College of Obstetricians and Gynaecologists
  • Ovarian Cysts in Postmenopausal Women [2016]

United States of America

• Agency for Healthcare Research and Quality
  • Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women [2017]
  • Menopausal Symptoms: Comparative Effectiveness of Therapies [2015]
  • Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions [2012]

• American Association of Clinical Endocrinologists
  • American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update [2017]

• American College of Obstetricians and Gynecologists
  • Compounded Bioidentical Menopausal Hormone Therapy [2012]

• American Society for Reproductive Medicine
  • Menopause

• Endocrine Society
  • Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline [2015]
  • Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement [2010]

• National Cancer Institute
  • Menopausal Hormone Therapy and Cancer

• North American Menopause Society
  • Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling [2020]
  • Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois [2020]
  • The 2017 hormone therapy position statement of The North American Menopause Society [2017]
  • Scientific Background Report for the 2017 Hormone Therapy Position Statement of The North American Menopause Society [2017]
  • The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65 [2015]
  • NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older [2015]
  • Why the product labeling for low-dose vaginal estrogen should be changed [2014]
  • The North American Menopause Society Recommendations for Clinical Care of Midlife Women [2014]
  • Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society [2014]
  • Clinical Care Recommendations

• Obstetrics & Gynecology Clinics of North America
  • The SWAN Song: Study of Women’s Health Across the Nation’s Recurring Themes [2011]
  • Reproductive Hormones and the Menopause Transition [2011]
  • Physical Activity and Health During the Menopausal Transition [2011]
  • Menstruation and the Menopause Transition [2011]
  • Adrenal Androgens and the Menopausal Transition [2011]

• Society of Gynecologic Oncology
  • Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement [2020]

• U.S. Pharmacist
  • Hormone Replacement Therapy for Menopausal Symptoms [2018]

• U.S. Preventive Services Task Force
  • Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions [2017]

{Related topics}

• Guidelines
  • Osteoporosis
  • Menopause: alternative therapy
  • Menopause, hormone replacement therapy: hot flashes, vasomotor symptoms
  • Menopause, hormone replacement therapy: genitourinary syndrome, sexual disorders
  • Menopause, hormone replacement therapy: abnormal bleeding
  • Menopause, hormone replacement therapy, mental disorders
  • Menopause, hormone replacement therapy, cardiovascular disease
  • Menopause, hormone replacement therapy, breast cancer